Veterinary Medicines

PASTERBACT

Authorised
  • Mannheimia haemolytica, Serotype A1, Strain 2806, Leucotoxoid
Download as PDF

Product identification

Medicine name:
PASTERBACT
Active substance:
  • Mannheimia haemolytica, Serotype A1, Strain 2806, Leucotoxoid
Target species:
  • Sheep
  • Goat
  • Cattle (calf)
  • Sheep (lamb)
  • Goat (kid)
  • Cattle (cow)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Mannheimia haemolytica, Serotype A1, Strain 2806, Leucotoxoid
    20.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Goat (kid)
      • Meat and offal
        0
        day
    • Cattle (cow)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Goat (kid)
      • Meat and offal
        0
        day
    • Cattle (cow)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Spanish Agency For Medicines And Medical Devices
Authorisation number:
  • 2856 ESP
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025
Download